🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21303Original Research

Effects of antioxidant pretreatment on skeletal muscle damage and oxidative stress following acute high-intensity exercise: a meta-analysis

Xia Caigui¹,Li Wei¹,Su Yuying¹,Shi Yu¹,Yang Zhonghe¹

Beijing Sport University, Beijing 100084, China

Read Executive PreviewQuick FAQ
Effects of antioxidant pretreatment on skeletal muscle damage and oxidative stress following acute high-intensity exercise: a meta-analysis
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1898, Issue 26 • pp. 100-112Citation:Xia Caigui et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Antioxidant pretreatment significantly reduces post-exercise serum creatine kinase, interleukin-6, and malondialdehyde levels, while enhancing glutathione peroxidase activity and total antioxidant capacity. • Low-dose (≤500 mg/d) short-term (≤14 d) antioxidant supplementation is more effective in suppressing malondialdehyde levels, whereas high-dose long-term intervention may inhibit exercise adaptation. • Training status significantly moderates the effect: general athletes show greater reduction in malondialdehyde levels than elite athletes. • Short-term high-dose antioxidant supplementation is recommended for rapid recovery during competition periods, but long-term use should be carefully weighed against potential inhibition of training adaptations.
Sponsored Research Highlight

Abstract

OBJECTIVE: Current evidence indicates that exercise-induced oxidative stress involves a dual role of reactive oxygen species, which participate in exercise adaptation while potentially causing tissue damage, highlighting the necessity for precise regulation of antioxidant dosage and timing. This study employs a Meta-analytic approach to systematically evaluate the effects of antioxidant pretreatment on biomarkers of skeletal muscle oxidative stress injury following acute strenuous exercise, and to explore the moderating effects of dosage, intervention duration, and training status. METHODS: A systematic search was conducted for randomized controlled trials that investigated the effects of antioxidant pretreatment on exercise-induced oxidative stress in PubMed, Web of Science, EBSCO, CNKI, VIP and WanFang databases from inception to February 2025. Literature quality was assessed using the physiotherapy evidence database scale. Data analysis was performed using RevMan 5.4 and Stata statistical software. RESULTS: (1) This meta-analysis included 16 studies from 12 publications, comprising 264 athletes and regularly exercising individuals. (2) The physiotherapy evidence database scale scores ranged from 6-8 (7 studies) to 9 (5 studies), indicating overall high methodological quality. (3) Meta analysis results showed that antioxidant pretreatment significantly decreased post-exercise serum creatine kinase [standardized mean difference (SMD)=-0.31, 95% confidence interval (CI) (-0.63, 0.00), P=0.05], interleukin-6 [SMD=-0.66, 95%CI (-1.03, -0.29), P=0.0005], and malondialdehyde levels [SMD=-1.10, 95%CI (-1.96, -0.23), P=0.01], and increased glutathione peroxidase activity [SMD=1.33, 95%CI (0.87, 1.78), P < 0.00001] and total antioxidant capacity [MD=4.77, 95%CI (3.87, 5.67), P < 0.00001]. Subgroup analysis showed that low-dose (≤500 mg/d) short-term (≤14 d) intervention had a more significant inhibitory effect on malondialdehyde levels (SMD=-1.15), while high-dose long-term intervention may inhibit exercise adaptation. Training status significantly moderated the effect size, with general athletes showing greater reduction in malondialdehyde levels than elite athletes (P < 0.05). CONCLUSION: Antioxidant pretreatment can effectively alleviate oxidative stress damage induced by acute strenuous exercise, but its effect is influenced by dosage, intervention duration, and training status. Short-term high-dose supplementation is suitable for rapid recovery during competition periods, while long-term application requires weighing antioxidant benefits against the risk of adaptation inhibition.

1. Introduction

Oxidative stress is a pathophysiological process in which the body produces excessive free radicals and/or exceeds its own scavenging capacity when subjected to external stimuli, leading to an imbalance in the redox system [1]. Since DILLARD et al. [2] first discovered in 1978 that exercise can increase lipid peroxidation levels, numerous studies have shown that both short-duration high-intensity and prolonged endurance exercise can induce oxidative stress, resulting in skeletal muscle damage, exercise-induced fatigue, and decreased exercise performance [3-4]. During strenuous exercise, rapid skeletal muscle contraction leads to a surge in reactive oxygen species (ROS) production from the mitochondrial electron transport chain, while pathways such as xanthine oxidase and NADPH oxidase are also activated, further exacerbating ROS generation [5]. When ROS concentrations exceed the scavenging capacity of the endogenous antioxidant system, lipid peroxidation, protein carbonylation, and DNA oxidative damage occur, ultimately leading to exercise-induced oxidative stress injury [6-7].

The discordance between the physiological and pathological roles of ROS is a core contradiction in current research. Physiological levels of ROS act as signaling molecules, activating the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway to promote antioxidant enzyme expression, thereby enhancing the body's adaptation to exercise [8-10]. However, excessive ROS disrupt calcium homeostasis, impair mitochondrial function, and exacerbate muscle fatigue by reducing sarcoplasmic reticulum Ca²⁺ release efficiency [11-12]. Studies have shown that blood markers of oxidative damage, such as creatine kinase and malondialdehyde, are significantly elevated after exercise and are positively correlated with muscle soreness and decreased strength [13-14]. Therefore, how to balance the physiological and pathological effects of ROS through exogenous antioxidant intervention has become an important topic in sports medicine.

The application strategy of antioxidants is controversial. Antioxidants are substances that have been proven to reduce the impact of reactive oxygen and nitrogen species in the human body [15], and are typically classified as exogenous or endogenous [16]. Early studies showed that classic antioxidants such as vitamin C and vitamin E can reduce post-exercise oxidative damage by scavenging free radicals [17-18]. However, recent studies have indicated that long-term high-dose antioxidant supplementation may inhibit the exercise-induced activation of the endogenous antioxidant system, interfere with the Nrf2 signaling pathway, and thereby weaken training adaptations [19-21]. This complexity of dose and timing results in high heterogeneity in the clinical efficacy of antioxidants [22]. Currently, there is no clear consensus on the moderating effects of antioxidant pretreatment dosage [17-18], intervention duration, and training status on effect sizes and their mechanisms [23-27], necessitating analysis to provide evidence-based guidance for optimizing sports nutrition supplementation strategies.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Xia Caigui, Li Wei, Su Yuying, Shi Yu, Yang Zhonghe (2026). Effects of antioxidant pretreatment on skeletal muscle damage and oxidative stress following acute high-intensity exercise: a meta-analysis. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21303
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the effect of antioxidant pretreatment on muscle damage markers after acute high-intensity exercise?

Antioxidant pretreatment significantly reduces post-exercise serum creatine kinase (SMD=-0.31, 95%CI -0.63 to 0.00, P=0.05) and interleukin-6 levels (SMD=-0.66, 95%CI -1.03 to -0.29, P=0.0005), indicating a protective effect against muscle damage.

How does antioxidant dosage and duration influence oxidative stress markers?

Subgroup analysis revealed that low-dose (≤500 mg/d) short-term (≤14 d) antioxidant supplementation is more effective in reducing malondialdehyde levels (SMD=-1.15), while high-dose long-term intervention may inhibit exercise adaptation.

Does training status affect the response to antioxidant pretreatment?

Yes, training status significantly moderates the effect. General athletes showed a greater reduction in malondialdehyde levels compared to elite athletes (P < 0.05), suggesting that less trained individuals may benefit more from antioxidant pretreatment.

What is the clinical recommendation for antioxidant use in athletes?

Short-term high-dose antioxidant supplementation is recommended for rapid recovery during competition periods. However, long-term use should be carefully weighed against potential inhibition of training adaptations, as high-dose long-term intervention may suppress the beneficial effects of exercise-induced oxidative stress on adaptation.

What biomarkers were assessed in this meta-analysis?

The meta-analysis assessed serum creatine kinase, interleukin-6, malondialdehyde, glutathione peroxidase activity, and total antioxidant capacity as biomarkers of oxidative stress and muscle damage.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF